| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 14,833,900 | 12,961,400 | 12,559,000 | 12,774,700 | | Cost of Revenue | 13,889,800 | 11,991,400 | 11,634,400 | 11,841,100 | | | Gross Profit | 944,100 | 970,000 | 924,600 | 933,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 340,300 | 381,000 | 347,200 | 368,400 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 75,900 | 73,900 | 71,100 | 70,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 527,900 | 515,100 | 506,300 | 494,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,500 | 6,200 |
-
|
-
| | Earnings Before Interest And Taxes | 531,400 | 521,300 | 506,300 | 494,600 | | Interest Expense | 45,100 | 63,800 | 58,100 | 57,500 | | Income Before Tax | 486,300 | 457,500 | 448,200 | 437,100 | | Income Tax Expense | 195,300 | 183,200 | 152,500 | 174,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 291,000 | 274,300 | 295,700 | 262,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 291,000 | 274,300 | 295,700 | 262,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $291,000 | $274,300 | $295,700 | $262,700 |
|
0.45% Nasdaq 
0.20%
Income Statement
